Skip to content

LoFric® Origo™ 44316 (REF 4431640)Recalls & reported problems

Wellspect AB · Single Use Urinary Catheter with salt solution. LoFric Origo, Nelaton 40cm CH16 / Nelaton 16" 16FR, Sterile device. · Class 2

All models of LoFric Origo (12)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07392532122538), received between Oct 9, 2019 and Oct 9, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 9, 2019Insufficient Device Problem Information; Insufficient Device Problem Information

    ACCORDING TO THE REPORTER, THE PATIENT EXPERIENCED A BLEEDING DURING URINARY CATHETERIZATION, AND THEREFORE NEEDED TO SEEK MEDICAL CARE AT THE HOSPITAL. THE PATIENT STAYED AT HOSPITAL OVERNIGHT, AND HE RECOVERED WELL. THE PATIENT'S PARTNER REPORTS THAT HE MIGHT NOT HAS USED THE CATHETER PROPERLY. THE INCIDENT OCCURED IN (B)(6).

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 9171539 ↗

Other CATHETER, STRAIGHT devices

All CATHETER, STRAIGHT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page